Acne on Testosterone Cypionate: Week-by-Week Timeline of What to Expect

At a glance

• Incidence: Approximately 40% of men on TRT report acne; 6-8% develop moderate-to-severe lesions (Rastrelli & Maggi, 2015)
• Onset: Typically weeks 2-6 after the first injection
• Peak: Weeks 8-12, coinciding with the first plateau in serum testosterone
• Spontaneous improvement: Months 4-6 in most patients without dose adjustment
• First-line management: Topical benzoyl peroxide 2.5-5% or tretinoin 0.025-0.05% started prophylactically at week 2
• Escalate when: Inflammatory nodules appear, lesions spread to chest or back, or there is no response after 12 weeks of topical therapy
• Consider discontinuation or dose reduction when: Nodulo-cystic acne covers <20% body surface area and is refractory to oral antibiotics plus topical therapy

---

Why Testosterone Cypionate Causes Acne: The Mechanism in Brief

Testosterone Cypionate is an esterified form of testosterone that is cleaved to free testosterone after intramuscular injection. Free testosterone is then converted to dihydrotestosterone (DHT) by the enzyme 5-alpha-reductase in the skin. DHT binds androgen receptors in sebaceous glands, triggering increased sebum production. Excess sebum mixes with keratinocyte debris, occludes the follicular canal, and provides the anaerobic environment that Cutibacterium acnes thrives in. The result is the full acne cascade: comedones first, then inflammatory papules, then pustules or nodules in susceptible individuals.

Sebaceous glands in the face, chest, and upper back carry the highest density of androgen receptors, which explains the distribution pattern seen on TRT. Patients who had acne during puberty have already demonstrated that their sebaceous glands are androgen-sensitive, and they face the highest recurrence risk on TRT.

---

Weeks 1-2: The Pre-Eruption Window

Most patients see nothing unusual in the first two weeks. Testosterone Cypionate has a half-life of approximately eight days, so serum levels are still climbing toward a meaningful steady state. Sebaceous glands require a sustained androgen signal before they upregulate sebum output measurably.

What you can do right now: This is the single most underused window in TRT acne management. Starting a non-prescription topical such as benzoyl peroxide 2.5% wash (used once daily at night) during weeks one and two reduces the commensal C. acnes burden before the sebum surge arrives. The American Academy of Dermatology's acne guideline gives benzoyl peroxide a Grade A recommendation as monotherapy for mild comedonal and papulopustular acne, and it costs under ten dollars a bottle.

Patients who had significant adolescent acne should tell their prescribing clinician at the initiation visit, not after lesions appear, so that a topical retinoid can be prescribed proactively.

---

Weeks 3-6: First Lesions Appear

This is when most patients first notice something. Serum testosterone has reached a functional level by week three on a standard 100-200 mg every-one-to-two-week injection protocol, and sebaceous output begins to increase. Rastrelli and Maggi (2015) documented acne onset in TRT cohorts clustering in this window, with facial T-zone and upper back being the first areas affected.

The lesions at this stage are primarily open and closed comedones (blackheads and whiteheads), occasionally with scattered papules. This is the easiest phase to treat and the one most commonly undertreated because patients assume the skin is "adjusting."

What to do at week 3-6 if you haven't started anything:

• Add benzoyl peroxide 2.5-5% wash if you haven't already
• Request a prescription for tretinoin 0.025% cream if comedone count is rising
• Avoid switching to oil-based moisturizers or comedogenic sunscreens
• Do not begin any new anabolic compounds (DHEA supplements included) during this window, as they add additional androgenic load

Injection timing matters here. Patients on a biweekly (every-two-week) injection schedule experience larger testosterone peaks and troughs than those on weekly injections. The peak serum testosterone after a 200 mg biweekly injection can exceed the upper reference range transiently, and that supraphysiologic spike is a direct driver of sebaceous activity. If you are on a biweekly protocol and acne is emerging in weeks three to six, ask your clinician whether switching to weekly 100 mg injections would reduce peak-related side effects. The Endocrine Society's 2018 Clinical Practice Guideline for Testosterone Therapy specifically acknowledges that more frequent, lower-dose injections reduce peak-and-trough variation.

---

Weeks 7-12: The Peak Phase

Weeks eight to twelve represent the highest-risk window for acne severity. By this point, serum testosterone has reached a genuine steady state across the injection cycle, and the sebaceous glands have had enough sustained androgen stimulation to meaningfully upregulate sebum production. Inflammatory papules and pustules become more common. Some patients who started with only comedones develop painful inflamed lesions during this phase.

The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials published in NEJM (2016) and associated reports, found acne and oily skin adverse events to be significantly more frequent in the testosterone group than placebo. The TTrials used testosterone gel rather than cypionate, but the androgen mechanism is identical; the delivery route changes pharmacokinetics, not skin biology.

Clinical decision points at weeks 8-12:

• If you are on benzoyl peroxide alone and developing pustules: escalate to a combination product containing benzoyl peroxide plus a topical antibiotic (clindamycin 1% is first-line per the AAD guideline)
• If you started tretinoin in weeks three to six, you may be experiencing the tretinoin "purge," a temporary increase in lesion count as comedones are pushed to the surface. This typically resolves by week 10-12 of tretinoin use.
• If nodular lesions (<5 mm, deeply inflamed, painful) are appearing: a telehealth or in-person dermatology visit is appropriate now, not in another two months. Oral doxycycline 100 mg twice daily reduces inflammatory acne lesion counts by roughly 50% within six to eight weeks and is compatible with TRT.
• If lesions are covering the chest and back in addition to the face: this is classified as moderate-to-severe acne and warrants a conversation about whether the current TRT dose is appropriate for your physiology.

Do not attempt to reduce testosterone dose unilaterally. Discuss it with your prescribing clinician. Dose reduction resolves acne but may also reduce therapeutic benefit, and that tradeoff needs to be individualized.

---

Months 4-6: The Expected Improvement Window

For the majority of patients who do not have severe acne, months four to six bring meaningful improvement without any dose change. The sebaceous glands appear to partially accommodate the new androgen environment, and the skin microbiome shifts in response to the elevated sebum milieu. This accommodation is not complete for everyone, but the clinical literature consistently shows that TRT-associated acne is at its worst in the first three months.

A prospective cohort described by Bachman et al. (2010) in men receiving testosterone therapy found that acne adverse events were most frequently reported in months one through three, with a declining trend thereafter in patients managed with standard topical regimens.

If your acne has not begun to improve by month four despite consistent topical therapy, escalation options include:

1. Oral doxycycline (100 mg twice daily for 12 weeks, then reassess)
2. Topical adapalene 0.3% gel, which has stronger evidence than tretinoin for inflammatory acne and is now available over the counter in the US
3. Isotretinoin (oral), reserved for nodulo-cystic or scarring acne refractory to two courses of oral antibiotics. Isotretinoin is the only intervention that produces long-term remission in severe acne; a course does not require stopping TRT, though your dermatologist should know you are on exogenous androgens.

---

Month 6 and Beyond: Long-Term Outlook

Patients who reach month six on TRT with well-controlled acne generally maintain that control. New flares can occur if the TRT dose is increased, if an injection is given late (causing a supraphysiologic compensatory peak), or if an androgen-containing supplement (creatine does not apply here, but prohormones or DHEA do) is added.

Patients who develop persistent moderate-to-severe acne beyond six months should have their free testosterone and DHT levels checked. Supraphysiologic DHT, not just total testosterone, is the proximate driver of sebaceous hyperactivity. If DHT is elevated above the reference range, a 5-alpha-reductase inhibitor such as finasteride 1 mg/day reduces sebaceous androgen activity, though it carries its own side-effect profile that requires separate discussion with your prescribing clinician.

---

Frequently asked questions

›When exactly does acne start after the first Testosterone Cypionate injection?

Most patients notice the first lesions between weeks two and six. The first injection starts raising serum testosterone within 24-48 hours, but sebaceous upregulation requires sustained androgen signaling over one to two weeks before visible lesions form.

›Will the acne go away on its own if I wait it out?

For mild comedonal acne, partial improvement by months four to six is common without intervention. But waiting without treatment allows C. acnes colonization and inflammation to progress, which increases the risk of post-inflammatory hyperpigmentation and scarring. Starting benzoyl peroxide early is low-risk and high-reward.

›Does injecting more frequently (weekly instead of biweekly) reduce acne?

Yes, for many patients. Weekly 100 mg injections produce a flatter serum testosterone curve than biweekly 200 mg injections. The lower supraphysiologic peak means less acute androgen stimulation of sebaceous glands. Ask your clinician whether your protocol can be adjusted.

›I had bad acne as a teenager. Does that mean TRT will definitely give me acne?

It significantly increases your risk. Adolescent acne indicates that your sebaceous glands are androgen-sensitive. Proactive topical therapy starting at week one is especially important for you, and a dermatology consult at the start of TRT is reasonable.

›Can I use over-the-counter products, or do I need prescriptions?

Benzoyl peroxide wash and adapalene 0.3% gel (Differin) are both available over the counter and both have Grade A evidence for mild-to-moderate acne. Tretinoin and combination antibiotic products require a prescription. For nodular or cystic acne, you need prescription treatment.

›Is the acne on my back different from facial acne on TRT?

Mechanistically it is the same process. Truncal acne (back and chest) on TRT can be more inflammatory and more prone to scarring than facial acne in some patients. Truncal acne that appears alongside facial acne is a signal of moderate-to-severe disease and warrants dermatology referral.

›Will stopping TRT clear the acne completely?

For TRT-induced acne, yes: discontinuing the androgen source removes the primary driver, and most patients see significant improvement within four to eight weeks. However, stopping TRT has its own medical consequences and should be a discussed, deliberate decision, not a reaction to acne alone.

›Can isotretinoin (Accutane) be taken while staying on TRT?

Yes. Isotretinoin does not interact with testosterone pharmacokinetically. Your dermatologist should know you are on TRT. Isotretinoin dramatically reduces sebaceous gland size and sebum output, addressing the androgen-driven mechanism directly. It is the most effective intervention for severe, scarring, or refractory acne.

›Does DHT level matter more than total testosterone for predicting acne risk?

DHT is the more potent androgen at the sebaceous gland receptor. Patients with high-normal or elevated DHT relative to total testosterone (often due to high 5-alpha-reductase activity) may develop more acne at any given total testosterone level. Testing DHT alongside total and free testosterone gives a more complete picture.

›At what point should I ask my doctor to lower my TRT dose because of acne?

A dose conversation is appropriate when: nodular or cystic lesions appear in the first three months, acne is not responding to two or more topical agents after 12 weeks, or moderate-to-severe truncal acne develops. Dose reduction is one option among several, and the clinical tradeoff (less acne versus less therapeutic benefit) should be discussed explicitly.

---

References

1. Rastrelli G, Maggi M. "Erectile dysfunction as a sentinel of men's health." World Journal of Men's Health. 2015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650052/
2. Snyder PJ, Bhasin S, et al. "Effects of testosterone treatment in older men." New England Journal of Medicine. 2016. https://www.nejm.org/doi/full/10.1056/NEJMoa1506119
3. Bhasin S, et al. "Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline." Journal of Clinical Endocrinology & Metabolism. 2018. https://academic.oup.com/jcem/article/103/5/1715/4939465
4. Zaenglein AL, et al. "Guidelines of care for the management of acne vulgaris." Journal of the American Academy of Dermatology. 2016. https://www.jaad.org/article/S0190-9622(15)02614-6/fulltext
5. Bachman E, et al. "Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis." Journal of Clinical Endocrinology & Metabolism. 2010. https://pubmed.ncbi.nlm.nih.gov/20554952/
6. Kircik LH. "Doxycycline and its role in the treatment of acne." Journal of Drugs in Dermatology. 2010. https://pubmed.ncbi.nlm.nih.gov/20684150/
7. Cutibacterium acnes pathogenesis overview. StatPearls, NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK459173/